Envista Holdings (NVST) stock
Members see every stock ranked and every check behind each score, live.
Why NVST scores 7
AverageTrending up, 3 of 13 possible checks firingWhat the Quality Score means
- +3Momentum traits 3 firing right now, of 13 possible, one point each
- +2Profit Made $95M over the last four quarters, up 77% from $54M the four before, from the SEC filings
- Long-term trend adds
- Growth adds
What's next
Expected to report Wed Oct 28, after the close
After its last 4 reports it closed +1.0% on average, higher 2 of 4 times.
What would move NVST's score: 5 things, for members
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.
NVST has 3 of a possible 13 checks firing
14 checks. Two are opposites (heavy volume and quiet volume), so at most 13 are on at once. One per group is shown here.
How NVST ranks in Healthcare
NVST is #149 of 517 by Quality Score. The top three are shown with their scores, and the rest by name.
CDNA9/1321
NTRA9/1321
CON8/1319
ABBVOpen for its score
TGTXOpen for its score
NVST3/137
When does NVST report, and what happens after?
Expected to report Wed Oct 28, after the close (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 5, 2026After close | After close | +0.2% | -4.4% | +0.3% |
| May 6, 2026After close | After close | +8.4% | -10.3% | -11.6% |
| Feb 5, 2026After close | After close | +12.9% | +17.8% | +16.4% |
| Oct 29, 2025After close | After close | +3.1% | +0.8% | +0.8% |
About Envista Holdings
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of NVST's score, with the points and the reason
- All 14 checks on NVST and on all 2,950 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on NVST
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week traits rest on real history. Options flow is not part of the product.
What does it cost?
One plan with everything in it: $29 a month, $69 for three months, or $249 a year. You pick the billing period when the trial ends, and payments go through Stripe, so Breakaway never sees your card.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.